F17I (p.Phe17Ile) variant of BEST1 (Bestrophin-1)

F17I (p.Phe17Ile) in BEST1 (Bestrophin-1) is a missense change. Clinical records from ClinVar, EBI, and UniProt describe it as likely pathogenic in the context of not provided. The available variant effect predictions contribute to a CATVariant prioritization score of 0.85 / 1. The record also includes structural context.

F17I (p.Phe17Ile) variant details